Prelude therapeutics to participate in three healthcare investor conferences in may

Wilmington, del., april 27, 2023 (globe newswire) -- prelude therapeutics incorporated (nasdaq: prld), a clinical-stage precision oncology company, today announced that company executives will participate in three upcoming healthcare investment conferences.

PRLD Ratings Summary

PRLD Quant Ranking